In December 2023, the U.S. Supreme Court heard oral arguments in the case of Harrington v. Purdue Pharma, L.P., Case No. 23-124. Purdue Pharma is the drug manufacturer of the prescription opioid, OxyContin, an alleged contributor to a major public health crisis involving loss of life due to overdose. Chrisandrea Turner takes a look at the case in this Stites & Harbison Client Alert.

The federal No Surprises Act (the “NSA”) requires all healthcare service providers to provide accurate and reliable cost estimates (Good Faith Estimates) to patients paying cash for services. The NSA’s Good Faith Estimate requirement has not received the media or industry press enjoyed by the balance billing prohibitions applicable to out-of-network (“OON”) emergency services providers, OON ancillary service providers at in-network facilities, and OON air ambulance providers, but may actually be the biggest surprise in the NSA.

The party seemed just like any other Stites & Harbison Groundhog Day party — great food, drinks, music, plenty of networking and, of course, the typical bad weather. But that didn’t stop the community from returning to celebrate Punxsutawney Phil’s big day last week.

Law360 (January 24, 2022, 1:17 PM EST) -- Stites & Harbison PLLC has added 12 Copeland Stair Kingma & Lovell LLP attorneys and all seven of Owen Gleaton Egan Jones & Sweeney LLP's attorneys to its Atlanta office, the firm recently announced.

ATLANTA—Stites & Harbison, PLLC announces that all seven attorneys from Owen, Gleaton, Egan, Jones & Sweeney, LLP have joined Stites & Harbison’s Atlanta office.

With Governor Andy Beshear’s June 24, 2021 Executive Order, Kentucky joins a growing minority of states allowing student-athletes to receive compensation for the use of their name, image, and likeness (NIL). Effective July 1, the Order applies to student-athletes at all postsecondary institutions in Kentucky.